WallStreetZenWallStreetZen

NASDAQ: TNYA
Tenaya Therapeutics Inc Stock Ownership - Who owns Tenaya Therapeutics?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Tenaya Therapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Faraz AliChief Executive Officer2025-03-103,947$0.54
$2.12kSell
Tomohiro HigaSVP Finance2025-03-10620$0.54
$333.56Sell
Tomohiro HigaSVP Finance2025-03-10845$0.54
$454.61Sell
Faraz AliChief Executive Officer2025-03-105,794$0.54
$3.12kSell
Tomohiro HigaSVP Finance2025-03-101,017$0.54
$547.15Sell
Whittemore TingleyChief Medical Officer2025-03-101,727$0.54
$929.13Sell
Whittemore TingleyChief Medical Officer2025-03-104,073$0.54
$2.19kSell
Whittemore TingleyChief Medical Officer2025-03-101,598$0.54
$859.72Sell
David V. GoeddelDirector2025-03-0535,714,284$0.70
$25.00MBuy
Column Group III GP LP10% Owner2025-03-0535,714,284$0.70
$25.00MBuy

1 of 2

TNYA insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when TNYA insiders and whales buy or sell their stock.

TNYA Shareholders

What type of owners hold Tenaya Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Column Group III GP LP16.96%14,855,844$7.18MInsider
David V. Goeddel16.96%14,855,844$7.18MInsider
Column Group LLC10.73%9,400,290$4.54MInstitution
Casdin Capital LLC7.69%6,732,971$3.25MInstitution
Eli Casdin7.35%6,440,829$3.11MInsider
Blackrock Inc6.05%5,296,476$2.56MInstitution
Jpmorgan Chase Co5.89%5,155,596$2.49MInstitution
Vanguard Group Inc3.74%3,272,044$1.58MInstitution
Vr Adviser LLC1.78%1,555,556$751.33kInstitution
Morgan Stanley1.70%1,488,306$718.85kInstitution

1 of 3

TNYA vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
TNYA49.84%43.74%Net BuyingNet Buying
RVPH16.54%22.85%
FBLG15.74%16.01%Net Buying
VRCA32.61%53.56%Net SellingNet Selling
IMRX11.99%38.68%Net Buying
View Top Biotech Stocks

Tenaya Therapeutics Stock Ownership FAQ

Who owns Tenaya Therapeutics?

Tenaya Therapeutics (NASDAQ: TNYA) is owned by 49.84% institutional shareholders, 43.74% Tenaya Therapeutics insiders, and 6.43% retail investors. Column Group III GP LP is the largest individual Tenaya Therapeutics shareholder, owning 14.86M shares representing 16.96% of the company. Column Group III GP LP's Tenaya Therapeutics shares are currently valued at $7.06M.

If you're new to stock investing, here's how to buy Tenaya Therapeutics stock.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.